Blemish Spot Treatment (Salicylic Acid) 1%…

Date

April 22, 2026

Risk class

Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)

Status

Ongoing

Filed by

Island Kinetics, Inc. d.b.a. CoValence Laboratories

Product

Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.

Reason

Failed Stability Specifications

Distribution pattern

U.S. Nationwide

Quantity

28,163 bottles

Codes and lots

Lot#: 4228D2, 4229D1, Exp.: 07/31/2026 Lot#: 5147D2, Exp.: 04/30/2027

Recall started

April 1, 2026

Recall number

D-0487-2026

What should I do? Medicine recall: what to do

Source: FDA · Drug enforcement report, recall number D-0487-2026. The agency record governs; check it and the company before acting.